Previous SARS-CoV-2 infection was detected in 12 IBD patients (anti-TNF n = 9; of these, adalimumab n = 1, infliximab n = 8, vedolizumab n = 2, ustekinumab n = 1) and 3 healthy controls. The gene discussed is TNF; the disease is inflammatory bowel disease.